SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: sammaster who wrote (6146)4/12/2002 8:29:11 AM
From: tom pope  Respond to of 52153
 
i'm surprised that sepr didnt just sell shares for cash during the biotech bubble like mlnm abgx and others, instead of using converts and now have to pay interest

They probably thought they were effectively issuing new shares, and above the then current market. No reason to think they weren't caught up in the bubble too.



To: sammaster who wrote (6146)4/12/2002 9:22:02 AM
From: schzammm  Read Replies (1) | Respond to of 52153
 
"i'm surprised that sepr didnt just sell shares for cash during the biotech bubble like mlnm abgx and others, instead of using converts and now have to pay interest"

I believe MLNM issued convertible bonds at about the same time and ABGX just recently issued a convert. The ABGX converts might be interesting. It was not available to the public but will be registered for public sale in the future.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News